Company led medicines recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection, CLMR(23)A/01
Specific batches of the product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.
CLMR Number
CLMR(23)A/01
MDR Number
MDR 234-11/22
Company name
Mawdsley-Brooks & Company Limited
Product description
Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine]
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 200686 | 01/2024 | 5 x 1ml | 21/05/2021 |
Active ingredient: Fluphenazine
Fluphenazin-neuraxpharm® D 25 mg/ml Solution for Injection [unlicensed medicine]
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 202052 | 01/2024 | 5 x 1ml | 16/07/2021 |
Active ingredient: Fluphenazine
Brief Description of Problem
Specific batches of product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.
This recall is being issued as a company-led medicines recall as the products are only supplied to limited number of customers, and the manufacturer has full traceability of the product바카라 사이트™s distribution.
Remaining stock of the above batches should be quarantined and returned to Mawdsleys directly.
Company Contact for medical information enquiries
For medical information enquiries, please contact Michelle Biggs at michelle.biggs@mawdsleys.co.uk
Company Contact for stock enquiries
For stock information enquiries, please contact Andrea Dunlop at andrea.dunlop@mawdsleys.co.uk